The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
                
            References
                    | Link | Resource | 
|---|---|
| https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 | Mitigation Third Party Advisory US Government Resource | 
Configurations
                    Configuration 1 (hide)
                                
                                
  | 
                        
Configuration 2 (hide)
| AND | 
                                
                                
 
  | 
                        
Configuration 3 (hide)
| AND | 
                                
                                
 
  | 
                        
Configuration 4 (hide)
| AND | 
                                
                                
 
  | 
                        
Information
                Published : 2021-12-15 11:15
Updated : 2022-07-25 03:39
NVD link : CVE-2021-43935
Mitre link : CVE-2021-43935
JSON object : View
CWE
                
                    
                        
                        CWE-287
                        
            Improper Authentication
Products Affected
                baxter
- welch_allyn_q-stress_cardiac_stress_testing_system
 - welch_allyn_vision_express_holter_analysis_system
 - welch_allyn_xscribe_cardiac_stress_testing_system_firmware
 - welch_allyn_q-stress_cardiac_stress_testing_system_firmware
 - welch_allyn_xscribe_cardiac_stress_testing_system
 - welch_allyn_hscribe_holter_analysis_system_firmware
 - welch_allyn_hscribe_holter_analysis_system
 - welch_allyn_rscribe_resting_ecg_system
 - welch_allyn_diagnostic_cardiology_suite
 - welch_allyn_connex_cardio
 


